1. From the Division of Clinical Cancer Epidemiology, Department of Oncology-Pathology, Karolinska Institutet; Stockholms Sjukhem Foundation, Stockholm; Division of Clinical Cancer Epidemiology, Department of Oncology, Sahlgrenska Academy, Göteborg's University, Göteborg, Sweden; and the Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland